GlycoMark® Testing for Glycemic Control

This policy states that GlycoMark® (1,5-anhydroglucitol; 1,5-AG) testing for glycemic control is not covered. The assay, developed by Nippon Kayaku Co., Ltd., is explicitly a non-covered service under this policy, and documentation does not change coverage status.

"GlycoMark® assay (1,5-anhydroglucitol; 1,5-AG) for assessment of glycemic control is not covered."

Sign up to see full coverage criteria, indications, and limitations.